February 3, 2023 9:00 AM
Newmark announces it has arranged a refinancing loan for a physician-owned hospital facility located in Houston, Texas. The facility is 100% leased to two tenants, including an independent surgical hospital operator and national inpatient rehabilitation facility.
The refinancing totaled $44 million in proceeds on a non-recourse basis, reflecting a 70% loan-to-value leverage level. The financing was executed through a two-note structure that was placed with a regional bank and international mezzanine lender.
Senior Managing Directors John Nero and Jay Miele, Executive Managing Director Ben Appel and Senior Managing Director Michael Greeley of Newmark’s Healthcare Capital Markets group represented the borrower in the transaction. Associates Adam Goss and Ron Ott provided transactional support.
“We were pleased with this financing execution on behalf of our borrower. The ability to achieve 70% LTV on a non-recourse basis for this physician-owned surgical hospital is a positive indication that the market for healthcare real estate financing remains strong,” said Nero.
Newmark Group, Inc. (Nasdaq: NMRK), together with its subsidiaries (“Newmark”), is a world leader in commercial real estate, seamlessly powering every phase of the property life cycle. Newmark’s comprehensive suite of services and products is uniquely tailored to each client, from owners to occupiers, investors to founders, and startups to blue-chip companies. Combining the platform’s global reach with market intelligence in both established and emerging property markets, Newmark provides superior service to clients across the industry spectrum. Newmark generated revenues of approximately $3.1 billion for the twelve months ending September 30, 2022. Newmark’s company-owned offices, together with its business partners, operate from approximately 180 offices with nearly 6,700 professionals around the world. To learn more, visit nmrk.com or follow @newmark.
Discussion of Forward-Looking Statements about Newmark
Statements in this document regarding Newmark that are not historical facts are “forward-looking statements” that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the effects of the COVID-19 pandemic on the Company’s business, results, financial position, liquidity and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, Newmark undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Newmark’s Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K.